Vaccinations

UK invests billions in new biosecurity centre to strengthen pandemic preparedness

UK invests billions in a National Biosecurity Centre in Essex: Europe’s largest hub for vaccine development, and pandemic preparedness.

How patients can overcome needle phobia and get the COVID vaccine

Dr Deborah Lee, Dr Fox Online Pharmacy, explores what can be done to help patients who refuse the COVID-19 vaccination due to needle phobia.

What are the side effects of the Moderna vaccine?

Here we list some of the most common and uncommon side effects of the Moderna vaccine and discuss the latest trials on pediatric participants.

One in four people get Pfizer and AstraZeneca vaccine side effects

New data from the UK's vaccination programme suggests that one in four people get Pfizer and AstraZeneca vaccine side effects - with most peaking in the first 24 hours, then gone in two days.

South Africa will use Johnson & Johnson COVID vaccine

After stopping rollout in response to blood clot investigations, South Africa are now preparing to start using Johnson & Johnson COVID vaccines.

Researchers report malaria vaccine efficacy of 77%

Researchers from the University of Oxford and their partners have reported that the malaria vaccine, R21/Matrix-M, has demonstrated high-level efficacy of 77%.

Is the Indian ‘double mutation’ as dangerous as the UK mutation?

India broke records on Thursday (23 April) as more than 310,000 new COVID cases were documented in one day - is the Indian 'double mutation', B1617, as infectious as the UK mutation? 

European Commission prepares lawsuit against AstraZeneca

According to Politico, the European Commission is getting ready to file a lawsuit against AstraZeneca over COVID vaccine deliveries.

Cybersecurity threats to the COVID-19 vaccine

Raymond Pompon, Director of F5 Labs, looks at the cybersecurity threats to the COVID-19 vaccine amid the rise in cyber attacks since the onset of the pandemic.

UK mutation 45% more infectious than original COVID-19

The UK mutation of COVID-19, aka B117, has been found by scientists to be 45% more infectious than the original form of the virus.

Some countries can’t vaccinate population against COVID until 2023

In February, 16% of the world's population pre-ordered 70% of available COVID vaccines - now, researchers at Colombia University reveal that some poorer countries won't be able to vaccinate their population until 2023.

Pfizer says people will need third vaccine dose after 12 months

Pfizer CEO Albert Bourla suggested that fully vaccinated people would need their third vaccine dose, maybe 12 months after they got their second - the EU is currently in talks to secure a further 1.8 billion doses.

Child vaccination rates have declined since COVID-19 outbreak

According to a Kaiser Permanente study, the rate of recommended vaccine doses administered to children has dramatically decreased since the outbreak of COVID-19.

Trial finds York/Hull leishmaniasis vaccine is safe

A new vaccine, developed by researchers at the Hull York Medical School, to treat leishmaniasis has proved to be safe in the first clinical trials.

EU to create new contract with Pfizer for 1.8 billion doses

Yesterday (14 April) EU President Ursula von der Leyen announced that the Commission would create a third contract with Pfizer, for 1.8 billion doses between 2021 to 2023.

84% of young people willing to get vaccinated

Data from a MyVoice national survey has found that the percentage of young people who say they're willing to get vaccinated has risen to 84%.

Prioritising maternal and child health in the COVID-19 era

Mahesh Karra, Assistant Professor of Global Development Policy, discusses the importance of maternal and child health during the COVID pandemic.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders